BN ImmunoTherapeutics Starts Clinical Trials With Prostate Canc... (world's safest multivalent vaccine vecto...)

BN ImmunoTherapeutics Starts Clinical Trials With Prostate Cancer Vaccine

Date:6/4/2008

world's safest, multivalent vaccine vectors. Bavarian Nordic has ongoing contracts with the US government for the late-stage development and procurement of the company's third-generation smallpox vaccine, IMVAMUNE(R).

Bavarian Nordic is listed on the OMX Nordic Exchange Copenhagen under the symbol BAVA.

For more information, please visit: http://www.bavarian-nordic.com

"Safe Harbour" Statement under the Private Securities Litigation Reform Act of 1995:

Except for the historical information contained herein, this release contains "forward-looking statements" within the meaning of the Private Securities Reform Act of 1995. No "forward-looking statement" can be guaranteed, and actual results may differ materially from those projected. Bavarian Nordic undertakes no obligation to publicly update any "forward-looking statement", whether as a result of new information, future events, or otherwise. Additional information regarding risks and uncertainties is set forth in the current Annual Report and in Bavarian Nordic's periodic reports, if any, which we incorporate by reference.

SOURCE Bavarian Nordic A/S
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2
Related medicine technology :

1. Impliant Restarts Pivotal Clinical Trial for Patented TOPS(TM) Spine System
2. VIDEO: Femara(R) helps protect against return of breast cancer even when treatment starts several years after completing tamoxifen therapy
3. New Company Starts, Bridging the Development Gap in the Discovery of Cancer Drugs
4. Keryx Biopharmaceuticals, Inc. Announces Phase 2 Results on KRX-0401 (Perifosine) in Patients with Relapsed/Refractory Waldenstroms Macroglobulinemia at the 44th Annual Meeting of the American Society of Clinical Oncology
5. ViroDefense Inc Announces Selection of Poliovirus Antiviral Preclinical Candidate
6. BioElectronics Announces Profitability Breakeven and Additional Clinical Trials
7. Amicus Therapeutics Begins Phase 2 Clinical Trial of AT2220 in Pompe Disease
8. EntreMed Presents MKC-1 Phase 2 Data at American Society of Clinical Oncology Annual Meeting
9. ADVENTRX Presents CoFactor Data at the 2008 Annual Meeting of the American Society of Clinical Oncology (ASCO)
10. Valor Medical Reports Early Clinical Results of New Technology to Treat Cerebral Aneurysms
11. Anadys Pharmaceuticals Initiates Phase I Clinical Trial of ANA598

Post Your Comments:

(Date:12/4/2009)ANNAPOLIS, Md., Dec. 4 PharmAthene, Inc. (NYSE Amex: PIP ), a biodefense company developing medical countermeasures against biological and chemical threats, announced today the presentation of new d

(Date:12/4/2009)Opposes use of imported drugs often stored in tin cans and car trunks ,, WASHINGTON, Dec. 4 Today, the senior advocacy group RetireSafe urged the Senate to defeat the Dorgan Importation plan encomp

(Date:12/4/2009)BILLERICA, Mass., Dec. 4 Axsun Technologies, Inc., a wholly-owned subsidiary of Volcano Corporation (Nasdaq: VOLC ), today announced the initial development and successful testing of a novel integra

Breaking Medicine Technology:PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 2 PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 3 PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 4 PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 5 RetireSafe Urges Senate to Defeat Senate Amendment 2793 -- Says Senator Dorgan's Drug Importation Plan Puts Seniors at Risk 2 Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 2 Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 3 Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 4 Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 5 2009 winner of the Manpei Suzuki international prize for diabetes research announced 10958 1 Kaiser Permanente Public Relations Leader Wins PR People Award 62440 1 Kaiser Permanente Public Relations Leader Wins PR People Award 62440 2 Kaiser Permanente Public Relations Leader Wins PR People Award 62440 3 Wounded Vets CAREER Counselors Gather in Washington as Obama Announces Afghanistan Troop Buildup 62435 1 Wounded Vets CAREER Counselors Gather in Washington as Obama Announces Afghanistan Troop Buildup 62435 2

[0] PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop [0] RetireSafe Urges Senate to Defeat Senate Amendment 2793 -- Says Senator Dorgan's Drug Importation Plan Puts Seniors at Risk [0] Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging

...g Hepatitis C Therapies Shows Similar, Sustained... PEGINTRON Combination Th...,Corporation (NYSE: SGP ), a leader in hepatitis ...IDEAL study, the first large, randomized, clinical... hepatitis C:,PEGINTRON(TM) (peginterferon alfa-2b...

... to the American,Academy of Dermatology (AAD), 10-...eczema, an inflamed skin condition characterized b...ndition,s symptoms, which tend to,flare up in the ...URALS(R),has introduced the Eczema Care Moisturizi...ingredients to help manage the daily symptoms of e...

Schering-Plough Reports Top-Line Results of the IDEAL Study New AVEENO(R) Eczema Care Product Line Offers Breakthrough Formulas to Help Manage the Signs and Symptoms of Eczema

(Date:12/5/2009)NEW ORLEANS, Dec. 5 Leukemia and myeloproliferative disorders are serious and often deadly blood cancers. Research presented today at the 51st Annual Meeting of the American Society of Hematology int

(Date:12/5/2009)AVIVA today announced the launch of International Solutions, an innovative new international private medical insurance plan which follows the acclaimed modular design of its UK equivalent. In addition

(Date:12/4/2009)NEW YORK, Dec. 4 Care Investment Trust Inc. (NYSE: CRE ) ("Care" or the "Company") today announced that its Board of Directors has declared a dividend of $0.17 per share of common stock. The div

(Date:12/4/2009)WASHINGTON, Dec. 4 The American Association of Homes and Services for the Aging (AAHSA) applauds the Senate for ensuring that the Community Living and Supportive Services (CLASS) provisions remain i

(Date:12/4/2009)ANAHEIM, Calif., Dec. 4 Pamela Bowen, Chief Information Officer at Crescent Healthcare, was selected as a finalist for the "Chief Innovation Officer" Appy Award for transforming Crescent,s business w

[0] Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders [0] AVIVA's Private Health Insurance Products Solutions Go International [0] Care Investment Trust Inc. Declares Quarterly Dividend of $0.17 Per Share [0] Statement from AAHSA CEO Larry Minnix on the Failure of the Thune Amendment [0] Crescent CIO '09 Dreamforce Conference Speaker and Award Finalist

... The Oro Organization, LLC, an onl...tnership with Medical Hair Restoration. , ...2009 -- The Oro Organization, LLC, an online lead ...com, we wanted to partner with one of the industry...

... New York Manhattan based personal... injury rights of bicyclists hit by motor vehicles...21, 2009 -- As subway fares and the cost of gas ri..., , ,David Perecman, a leading New York personal ...

... May 21 Hispanic style cheese known as Queso Fre...ing and fighting obesity and other related health ...hat eating dairy foods while consuming a low-calor... the recommended daily intakes of calcium in dairy...

...pnea has long been known to be associated with obe... of Diabetes Care finds that the disorder is wid...2 diabetes nearly 87 percent of participants repo...ws that it can also mean an increased risk of hear...

...ON, May 20 The following is a Statement of Matthe...ds: , , (Logo: http://www.newscom.com/cgi-bin/...Tobacco-Free Kids applauds U.S. Senator Sherrod Br...rity over tobacco products, including the authorit...

... NorthShore University HealthSyste...cology. , Evanston, IL (V...l of Clinical Oncology, authored by David J. Winc...has spread to the lymph nodes may not need a radic...

Other Medicine News:Health News:The Oro Organization, LLC Partners with Medical Hair Restoration to Launch New Website USHairReplacement.com 2 Health News:New York Personal Injury Lawyer Seeks to Protect Bicyclists From Harm 2 Health News:Hispanic Cheese May Prevent Obesity 2 Health News:More than a bad night's sleep 2 Health News:Sen. Sherrod Brown Votes to Protect America's Kids from Tobacco 2 Health News:Sen. Sherrod Brown Votes to Protect America's Kids from Tobacco 3 Health News:Breast Cancer Patients May be Spared Additional Surgery 2 Health News:Breast Cancer Patients May be Spared Additional Surgery 3

The Oro Organization, LLC Partners with Medical Hair Restoration to Launch New Website USHairReplacement.com New York Personal Injury Lawyer Seeks to Protect Bicyclists From Harm Hispanic Cheese May Prevent Obesity More than a bad night's sleep Sen. Sherrod Brown Votes to Protect America's Kids from Tobacco Breast Cancer Patients May be Spared Additional Surgery

O'Brien Suprapubic Peel-Away® Access Set

Pereyra Ligature Carrier '75

Stratasis Urethral Sling,Freeze-Dried

van Andel Catheter

Medicine Products:

O'Brien Suprapubic Peel-Away® Access Set Pereyra Ligature Carrier '75 Stratasis Urethral Sling,Freeze-Dried van Andel Catheter

BN ImmunoTherapeutics Starts Clinical Trials With Prostate Canc...(world's safest multivalent vaccine vecto...),Health